Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4306) 4306
Book Chapter (332) 332
Dissertation (27) 27
Publication (19) 19
Newspaper Article (14) 14
Newsletter (12) 12
Conference Proceeding (6) 6
Magazine Article (4) 4
Book / eBook (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3290) 3290
science & technology (2963) 2963
life sciences & biomedicine (2901) 2901
mantle cell lymphoma (2623) 2623
male (1667) 1667
hematology (1393) 1393
middle aged (1379) 1379
oncology (1368) 1368
female (1352) 1352
lymphoma, mantle-cell - pathology (1312) 1312
aged (1291) 1291
lymphoma, mantle-cell - drug therapy (1088) 1088
lymphoma (915) 915
biological and medical sciences (870) 870
medical sciences (865) 865
adult (816) 816
lymphoma, mantle-cell - genetics (743) 743
lymphomas (732) 732
hematologic and hematopoietic diseases (719) 719
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (706) 706
lymphoma, mantle-cell - diagnosis (569) 569
aged, 80 and over (566) 566
antineoplastic combined chemotherapy protocols - therapeutic use (564) 564
lymphoma, mantle-cell - metabolism (526) 526
lymphoma, mantle-cell - therapy (522) 522
prognosis (516) 516
treatment outcome (496) 496
pathology (473) 473
rituximab (466) 466
hemic and lymphatic diseases (450) 450
abridged index medicus (415) 415
cancer (411) 411
lymphoma, mantle-cell - mortality (375) 375
antineoplastic agents - therapeutic use (371) 371
chemotherapy (370) 370
immunohistochemistry (370) 370
cell line, tumor (366) 366
care and treatment (304) 304
animals (300) 300
tumors (295) 295
immune system diseases (265) 265
flow cytometry (260) 260
follicular lymphoma (260) 260
diagnosis, differential (256) 256
cyclin d1 (243) 243
immunophenotyping (239) 239
leukemia (238) 238
translocation, genetic (238) 238
bortezomib (232) 232
analysis (231) 231
antineoplastic agents (231) 231
disease-free survival (230) 230
research (225) 225
apoptosis (224) 224
lymphoma, mantle-cell - complications (218) 218
lymphoma, mantle-cell - immunology (218) 218
recurrence (215) 215
survival analysis (211) 211
transplantation (207) 207
medicine & public health (203) 203
antibodies, monoclonal, murine-derived (201) 201
non-hodgkin's lymphomas (201) 201
retrospective studies (200) 200
survival rate (198) 198
chronic lymphocytic leukemia (196) 196
diagnosis (196) 196
gene expression (188) 188
patients (188) 188
mice (184) 184
combined modality therapy (183) 183
in situ hybridization, fluorescence (182) 182
mantle (178) 178
transplantation, autologous (172) 172
lymphocytes b (171) 171
stem cells (171) 171
remission induction (170) 170
cyclin d1 - genetics (168) 168
gene expression regulation, neoplastic (168) 168
neoplasm staging (166) 166
antineoplastic agents - pharmacology (165) 165
biopsy (165) 165
antineoplastic combined chemotherapy protocols - administration & dosage (163) 163
cyclophosphamide - administration & dosage (161) 161
genetic aspects (158) 158
hematopoietic stem cell transplantation (158) 158
cell biology (156) 156
hematology, oncology and palliative medicine (156) 156
cyclin d1 - metabolism (152) 152
follow-up studies (152) 152
non-hodgkin lymphoma (152) 152
apoptosis - drug effects (151) 151
cell cycle (147) 147
antibodies, monoclonal - therapeutic use (146) 146
mutation (146) 146
leukemia, lymphocytic, chronic, b-cell - pathology (142) 142
lymphoma, b-cell - pathology (142) 142
pharmacology. drug treatments (140) 140
immunology (138) 138
signal transduction (138) 138
lymphoma, follicular - pathology (134) 134
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4470) 4470
Chinese (89) 89
Japanese (68) 68
French (48) 48
German (40) 40
Spanish (35) 35
Czech (16) 16
Korean (16) 16
Portuguese (16) 16
Russian (14) 14
Polish (10) 10
Hungarian (6) 6
Italian (4) 4
Turkish (3) 3
Croatian (2) 2
Danish (2) 2
Slovak (2) 2
Dutch (1) 1
Norwegian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma
by Dreyling, M and Thieblemont, C and Gallamini, A and Arcaini, L and Campo, E and Hermine, O and Kluin-Nelemans, J.C and Ladetto, M and Le Gouill, S and Iannitto, E and Pileri, S and Rodriguez, J and Schmitz, N and Wotherspoon, A and Zinzani, P and Zucca, E
Annals of oncology, ISSN 0923-7534, 04/2013, Volume 24, Issue 4, pp. 857 - 877
mantle cell lymphoma | malignant lymphoma guidelines | T-cell lymphoma | marginal zone lymphoma | EUROPEAN-MCL-NETWORK | PROSPECTIVE RANDOMIZED-TRIAL | PROGRESSION-FREE SURVIVAL | BONE-MARROW-TRANSPLANTATION | LOW-GRADE LYMPHOMA | PHASE-II TRIAL | INTERNATIONAL PROGNOSTIC INDEX | HIGH-DOSE THERAPY | NON-HODGKINS-LYMPHOMA | MINIMAL RESIDUAL DISEASE | Mantle cell lymphoma | Marginal zone lymphoma | Malignant lymphoma guidelines | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Guidelines as Topic | World Health Organization | Europe | Humans | Lymphoma, Mantle-Cell - pathology | Lymphoma, B-Cell, Marginal Zone - therapy | Lymphoma, Mantle-Cell - diagnosis | Lymphoma, Mantle-Cell - therapy | Lymphoma, B-Cell, Marginal Zone - diagnosis | Lymphoma, T-Cell - therapy | Lymphoma, T-Cell - diagnosis | Lymphoma, T-Cell - pathology | Lymphoma, B-Cell, Marginal Zone - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Long non-coding RNAs guide the fine-tuning of gene regulation in B-cell development and malignancy
by Dahl, Mette and Kristensen, Lasse Sommer and Grønbæk, Kirsten
International journal of molecular sciences, ISSN 1661-6596, 09/2018, Volume 19, Issue 9, p. 2475
B-cell development | Burkitt lymphoma (BL) | Mantle cell lymphoma (MCL) | Gene regulation | Diffuse large b-cell lymphoma (DLBCL) | Circular RNA | Chronic lymphocytic leukemia (CLL) | Acute lymphoblastic leukemia (ALL) | Long non-coding RNA | Multiple myeloma (MM) | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Humans | Gene Expression Regulation, Neoplastic | Lymphoma, Mantle-Cell - pathology | Multiple Myeloma - immunology | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | RNA - genetics | Burkitt Lymphoma - pathology | RNA, Long Noncoding - immunology | Lymphoma, Follicular - genetics | Burkitt Lymphoma - immunology | Cell Transformation, Neoplastic - genetics | Burkitt Lymphoma - genetics | Lymphoma, Large B-Cell, Diffuse - immunology | Cell Differentiation | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Lymphoma, Mantle-Cell - genetics | Lymphoma, Large B-Cell, Diffuse - pathology | RNA - immunology | Signal Transduction | Lymphoma, Follicular - pathology | RNA, Long Noncoding - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Cell Transformation, Neoplastic - immunology | Multiple Myeloma - pathology | B-Lymphocytes - immunology | Lymphoma, Follicular - immunology | Lymphoma, Mantle-Cell - immunology | Cell Transformation, Neoplastic - pathology | Lymphoma, Large B-Cell, Diffuse - genetics | Multiple Myeloma - genetics | Transformation | Deregulation | Leukemia | Differentiation (biology) | Multiple myeloma | Effector cells | Genomes | Malignancy | Gene sequencing | Peripheral blood | Bone marrow | Clonal selection | Chronic lymphatic leukemia | Acute lymphatic leukemia | V(D)J recombination | Lymphatic leukemia | Gene expression | Ribonucleic acid--RNA | Lymphoma | Burkitt's lymphoma | Somatic hypermutation | Blood circulation | Lymphocytes B | Mantle cell lymphoma | Cancer | B-cell lymphoma | Genomics | Metastasis | Kinases | Proteins | Next-generation sequencing | Transfer RNA | Enzymes | Cyclin-dependent kinases | Acids | Protein synthesis | MicroRNAs | Binding sites | Index Medicus | diffuse large B-cell lymphoma (DLBCL) | chronic lymphocytic leukemia (CLL) | burkitt lymphoma (BL) | gene regulation | circular RNA | acute lymphoblastic leukemia (ALL) | long non-coding RNA | mantle cell lymphoma (MCL) | multiple myeloma (MM)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Non‐Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011
by Al‐Hamadani, Mohammed and Habermann, Thomas M and Cerhan, James R and Macon, William R and Maurer, Matthew J and Go, Ronald S
American journal of hematology, ISSN 0361-8609, 09/2015, Volume 90, Issue 9, pp. 790 - 795
Life Sciences & Biomedicine | Hematology | Science & Technology | United States | Humans | Middle Aged | Lymphoma, Follicular - diagnosis | Lymphoma, Mantle-Cell - pathology | Leukemia, Hairy Cell - mortality | Male | Lymphoma, B-Cell, Marginal Zone - mortality | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Lymphoma, Mantle-Cell - mortality | Lymphoma, Mantle-Cell - diagnosis | Lymphoma, Large-Cell, Anaplastic - diagnosis | Adult | Female | Lymphoma, B-Cell, Marginal Zone - pathology | B-Lymphocytes - pathology | T-Lymphocytes - pathology | Leukemia, Hairy Cell - pathology | Databases, Factual | Lymphoma, Follicular - pathology | Lymphoma, Follicular - mortality | Terminology as Topic | Burkitt Lymphoma - diagnosis | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Lymphoma, Large-Cell, Anaplastic - mortality | Leukemia, Hairy Cell - diagnosis | Lymphoma, B-Cell, Marginal Zone - diagnosis | Survival Analysis | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Lymphoma, Large-Cell, Anaplastic - pathology | Longitudinal Studies | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis | Databases | Non-Hodgkin's lymphomas | Native Americans | T cells | Analysis | Leukemia | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text B-cell lymphoma patient-derived xenograft models enable drug discovery and are a platform for personalized therapy
by Zhang, Leo and Nomie, Krystle and Zhang, Hui and Bell, Taylor and Pham, Lan and Kadri, Sabah and Segal, Jeremy and Li, Shaoying and Zhou, Shouhao and Santos, David and Richard, Shawana and Sharma, Shruti and Chen, Wendy and Oriabure, Onyekachukwu and Liu, Yang and Huang, Shengjian and Guo, Hui and Chen, Zhihong and Tao, Wenjing and Li, Carrie and Wang, Jack and Fang, Bingliang and Wang, Jacqueline and Li, Lei and Badillo, Maria and Ahmed, Makhdum and Thirumurthi, Selvi and Huang, Steven Y and Shao, Yiping and Lam, Laura and Yi, Qing and Wang, Y. Lynn and Wang, Michael
Clinical cancer research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4212 - 4223
Life Sciences & Biomedicine | Oncology | Science & Technology | Lymphoma, Follicular - drug therapy | Humans | Lymphoma, Mantle-Cell - pathology | Protein Kinase Inhibitors - adverse effects | Burkitt Lymphoma - pathology | Protein-Tyrosine Kinases - genetics | Lymphoma, Follicular - genetics | Burkitt Lymphoma - genetics | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - genetics | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Precision Medicine | Pyrazoles - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Drug Discovery | Lymphoma, B-Cell, Marginal Zone - genetics | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Agammaglobulinaemia Tyrosine Kinase | Lymphoma, B-Cell, Marginal Zone - drug therapy | Lymphoma, Large B-Cell, Diffuse - classification | Pyrimidines - adverse effects | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Cell culture | Therapy | Animal models | Kinases | Inactivation | Signal transduction | Biological effects | Peripheral blood | Xenografts | Remission | Protein-tyrosine kinase | Tyrosine | Deactivation | Tumor cells | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Burkitt's lymphoma | Signaling | Inhibitors | Lymphocytes B | Experimental design | Mantle cell lymphoma | Mutation | Tumors | Cancer | B-cell lymphoma | Index Medicus | patient-derived xenograft | personalized therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B‐ and T‐cell non‐Hodgkin lymphoma
by Witzig, Thomas E and Maurer, Matthew J and Habermann, Thomas M and Link, Brian K and Micallef, Ivana N.M and Nowakowski, Grzegorz S and Ansell, Stephen M and Colgan, Joseph P and Inwards, David J and Porrata, Luis F and Markovic, Svetomir N and Johnston, Patrick B and Lin, Yi and Thompson, Carrie and Gupta, Mamta and Katzmann, Jerry A and Cerhan, James R
American journal of hematology, ISSN 0361-8609, 12/2014, Volume 89, Issue 12, pp. 1116 - 1120
Life Sciences & Biomedicine | Hematology | Science & Technology | Prognosis | Lymphoma, B-Cell - blood | Humans | Lymphoma, B-Cell - diagnosis | Middle Aged | Lymphoma, Follicular - diagnosis | Lymphoma, Mantle-Cell - pathology | Lymphoma, Large-Cell, Immunoblastic - mortality | Male | Lymphoma, Mantle-Cell - mortality | Lymphoma, Mantle-Cell - diagnosis | Lymphoma, Follicular - blood | T-Lymphocytes - metabolism | Lymphoma, Mantle-Cell - blood | Female | Clone Cells | B-Lymphocytes - pathology | T-Lymphocytes - pathology | B-Lymphocytes - metabolism | Immunoglobulin kappa-Chains - blood | Immunoglobulin lambda-Chains - blood | Lymphoma, B-Cell - mortality | Lymphoma, Follicular - pathology | Lymphoma, Large-Cell, Immunoblastic - blood | Lymphoma, Follicular - mortality | Lymphoma, Large-Cell, Immunoblastic - diagnosis | Lymphoma, T-Cell - blood | B-Lymphocytes - immunology | Lymphoma, T-Cell - diagnosis | Lymphoma, B-Cell - pathology | Lymphoma, T-Cell - pathology | Survival Analysis | T-Lymphocytes - immunology | Aged | Lymphoma, T-Cell - mortality | Lymphoma, Large-Cell, Immunoblastic - pathology | Immunoglobulins | Lymphomas | T cells | Analysis | Medical research | Lymphoma | Medical prognosis | Index Medicus | free light chains | T-cell lymphoma | lymphoma | B-cell lymphoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Mantle cell lymphoma
by Cheah, Chan Yoon and Seymour, John F and Wang, Michael L
Journal of clinical oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 11, pp. 1256 - 1269
Life Sciences & Biomedicine | Oncology | Science & Technology | Lymphoma, Mantle-Cell - surgery | Prognosis | Humans | Gene Expression Regulation, Neoplastic | Lymphoma, Mantle-Cell - pathology | Induction Chemotherapy | Transplantation, Autologous | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Bortezomib - pharmacology | Thalidomide - pharmacology | Lymphoma, Mantle-Cell - diagnosis | Thalidomide - analogs & derivatives | Bendamustine Hydrochloride - administration & dosage | Maintenance Chemotherapy | Lymphoma, Mantle-Cell - metabolism | Molecular Targeted Therapy - methods | Pyrazoles - pharmacology | Drug Administration Schedule | Lenalidomide | Risk Factors | Hematopoietic Stem Cell Transplantation | Lymphoma, Mantle-Cell - drug therapy | Pyrimidines - pharmacology | Cytarabine - administration & dosage | Rituximab - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Staging | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma
by Phillips, Tycel and Phillips, Tycel and Barr, Paul M and Barr, Paul M and Park, Steven I and Park, Steven I and Kolibaba, Kathryn and Kolibaba, Kathryn and Caimi, Paolo F and Caimi, Paolo F and Chhabra, Saurabh and Chhabra, Saurabh and Kingsley, Edwin C and Kingsley, Edwin C and Boyd, Thomas and Boyd, Thomas and Chen, Robert and Chen, Robert and Carret, Anne-Sophie and Carret, Anne-Sophie and Gartner, Elaina M and Gartner, Elaina M and Li, Hong and Li, Hong and Yu, Cindy and Yu, Cindy and Smith, David C and Smith, David C
Investigational new drugs, ISSN 0167-6997, 4/2019, Volume 37, Issue 2, pp. 297 - 306
Mantle-cell lymphoma | Medicine & Public Health | Pyrrolobenzodiazepine dimer (PBD) | Grade 3 follicular lymphoma | Diffuse, large B cell, lymphoma (DLBCL) | Oncology | Pharmacology/Toxicology | CD70 antigen | Antibody-drug conjugate | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Prognosis | Follow-Up Studies | CD27 Ligand - antagonists & inhibitors | Humans | Middle Aged | Lymphoma, Mantle-Cell - pathology | Salvage Therapy | Immunoconjugates - pharmacokinetics | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Male | Lymphoma, Large B-Cell, Diffuse - metabolism | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Tissue Distribution | CD27 Ligand - metabolism | Lymphoma, B-Cell - immunology | Aged, 80 and over | Biomarkers, Tumor - metabolism | Immunoconjugates - therapeutic use | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - metabolism |